Quantitative evaluation of perfusion and permeability of peripheral tumors using contrast-enhanced computed tomography

Investigative Radiology

Volumn 39, Issue 6, 2004, Pages 340-349

  Pollard, Rachel E ^a   Garcia, Tanya C ^b   Stieger, Susanne M ^a   Ferrara, Katherine W ^b   Sadlowski, Amy R ^b   Wisner, Erik R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Computed tomography; CT; Perfusion; Permeability; Quantitative; Tumor

Indexed keywords

EVANS BLUE; IODINATED CONTRAST MEDIUM;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED COMPUTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMORAL ARTERY; FLUORESCENCE; IMAGE ANALYSIS; MALE; MEASUREMENT; NONHUMAN; PERFUSION; PERMEABILITY; PRIORITY JOURNAL; RAT; TUMOR;

EID: 2442666607     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01rli.0000124456.82985.35     Document Type: Article

References (30)

1. Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. Acad Radiol. 2000;7:800-811.
2. Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000;21:505-515.
3. Rosen LS. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control. 2002;9(2 Suppl):36-44.
4. Seghezzi G, Patel S, Ren CJ, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141:1659-73.
5. Klint P, Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci. 1999;4:D165-D177.
6. Rosenkranz S, Kazlauskas A. Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 1999;16:201-216.
7. Griffin RJ, Williams BW, Wild R, et al. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Res. 2002;62:1702-1706.
8. Shaheen RM, Tseng WW, Davis DW, et al. Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res. 2001;61:1464-1468.
9. Angelov L, Salhia B, Roncari I, et al. Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas. Cancer Res. 1999;59:5536-5541.
10. Mendel DB, Laird AD, Smolich BD, et al. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drug Des. 2000;15:29-41.
11. Hindmarsh T. Elimination of water-soluble contrast media from the subarachnoid space. Investigation with computer tomography. Acta Radiol Suppl. 1975;346:45-49.
12. Dawson P, Peters AM. What is the nephrogram? Br J Radiol. 1994;67:21-25.
13. Miles KA, Leggett DA, Bennett GA. CT derived Patlak images of the human kidney. Br J Radiol. 1999;72:153-158.
14. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol. 1991;64:409-12.
15. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol. 1999;30:198-205.
16. Harvey CJ, Blomley MJ, Dawson P, et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr. 2001;25:43-49.
17. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
18. Lykke AW, Cummings R. Increased vascular permeability in the primary cutaneous allograft response in the rat. Experientia. 1969;25:1287-1288.
19. Cenic A, Nabavi DG, Craen RA, et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol. 1999;20:63-73.
20. Gould RG, Lipton MJ, McNamara MT, et al. Measurement of regional myocardial blood flow in dogs by ultrafast CT. Invest Radiol. 1988;23:348-353.
21. Gjedde A. Origins of the Patlak plot. Nucl Med Commun. 1995;16:979-980.
22. Gobbel GT, Cann CE, Iwamoto HS, et al. Measurement of regional cerebral blood flow in the dog using ultrafast computed tomography. Experimental validation. Stroke 1991;22:772-779.
23. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol. 2001;46:3161-3175.
24. Bronikowski TA, Dawson CA, Linehan JH. Model-free deconvolution techniques for estimating vascular transport functions. Int J Biomed Comput. 1983;14:411-429.
25. Gamel J, Rousseau WF, Katholi CR, et al. Pitfalls in digital computation of the impulse response of vascular beds from indicator-dilution curves. Circ Res. 1973;32:516-523.
26. Blomley MJ, Coulden R, Bufkin C, et al. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion. Invest Radiol. 1993;28(Suppl 5):S72-S77; discussion S78.
27. Gossmann A, Helbich TH, Kuriyama N, et al. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging. 2002;15:233-240.
28. Cohen FM, Kuwatsuru R, Shames DM, et al. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol. 1994;29:970-977.
29. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging. 1997;7:68-74.
30. Aronen HJ, Cohen MS, Belliveau JW, et al. Ultrafast imaging of brain tumors. Top Magn Reson Imaging. 1993;5:14-24.